The emerging role of trace amine‐associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity

J. Neurochem. (2011) 116, 164–176.

[1]  H. Schoemaker,et al.  Tryptamine, a Substrate for the Serotonin Transporter in Human Platelets, Modifies the Dissociation Kinetics of [3H]Imipramine Binding: Possible Allosteric Interaction , 1985, Journal of neurochemistry.

[2]  S. Philips,et al.  Kinetic Measurements of the Turnover Rates of Phenylethylamine and Tryptamine In Vivo in the Rat Brain , 1980, Journal of neurochemistry.

[3]  E. Vallender,et al.  Normal thermoregulatory responses to 3‐iodothyronamine, trace amines and amphetamine‐like psychostimulants in trace amine associated receptor 1 knockout mice , 2010, Journal of neuroscience research.

[4]  Boulton Aa,et al.  Identification, Distribution, Metabolism, and Function of Meta and Para Tyramine, Phenylethylamine and Tryptamine in Brain , 1976 .

[5]  J. Moreau,et al.  Trace Amine-Associated Receptor 1 Modulates Dopaminergic Activity , 2008, Journal of Pharmacology and Experimental Therapeutics.

[6]  J. B. Justice,et al.  Human norepinephrine transporter kinetics using rotating disk electrode voltammetry. , 1996, Analytical chemistry.

[7]  R. Blakely,et al.  Rapid Stimulation of Presynaptic Serotonin Transport by A3 Adenosine Receptors , 2007, Journal of Pharmacology and Experimental Therapeutics.

[8]  G. Reynolds,et al.  DOES PHENYLETHYLAMINE CAUSE SCHIZOPHRENIA? , 1976, The Lancet.

[9]  A. Coppen,et al.  Tryptamine Metabolism in Depression , 1965, British Journal of Psychiatry.

[10]  A. Boulton,et al.  Distribution and metabolism of tryptamine in rat brain. , 1973, Canadian journal of biochemistry.

[11]  S. Philips,et al.  THE EFFECT OF MONOAMINE OXIDASE INHIBITORS ON SOME ARYLALKYLAMINES IN RAT STRIATUM , 1979, Journal of neurochemistry.

[12]  K. Neve,et al.  Release of dopamine via the human transporter. , 1994, Molecular pharmacology.

[13]  M. Hoener,et al.  A renaissance in trace amines inspired by a novel GPCR family. , 2005, Trends in pharmacological sciences.

[14]  A. Boulton,et al.  Biosynthesis and excretion of meta and para tyramine in the rat. , 1974, Life sciences.

[15]  S. Westmoreland,et al.  Rhesus Monkey Trace Amine-Associated Receptor 1 Signaling: Enhancement by Monoamine Transporters and Attenuation by the D2 Autoreceptor in Vitro , 2007, Journal of Pharmacology and Experimental Therapeutics.

[16]  A. Boulton.  AMINES AND THEORIES IN PSYCHIATRY , 1974 .

[17]  R. Blakely,et al.  Dysregulation of Dopamine Transporters via Dopamine D2 Autoreceptors Triggers Anomalous Dopamine Efflux Associated with Attention-Deficit Hyperactivity Disorder , 2010, The Journal of Neuroscience.

[18]  S. Paul,et al.  Specific [3H] beta-phenylethylamine binding sites in rat brain. , 1982, European journal of pharmacology.

[19]  S. Westmoreland,et al.  Functional evolution of the trace amine associated receptors in mammals and the loss of TAAR1 in dogs , 2010, BMC Evolutionary Biology.

[20]  D. Grandy,et al.  Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. , 2001, Molecular pharmacology.

[21]  H. Sitte,et al.  Carrier‐Mediated Release, Transport Rates, and Charge Transfer Induced by Amphetamine, Tyramine, and Dopamine in Mammalian Cells Transfected with the Human Dopamine Transporter , 1998, Journal of neurochemistry.

[22]  R. S. Jones,et al.  Interactions between p-tyramine, m-tyramine, or beta-phenylethylamine and dopamine on single neurones in the cortex and caudate nucleus of the rat. , 1980, Canadian journal of physiology and pharmacology.

[23]  M. Vatta,et al.  Endothelin-1 and -3 modulate the neuronal norepinephrine transporter through multiple signalling pathways in the rat posterior hypothalamus , 2010, Neurochemistry International.

[24]  T. Branchek,et al.  Trace amine receptors as targets for novel therapeutics: legend, myth and fact. , 2003, Current opinion in pharmacology.

[25]  Manuel Rodriguez,et al.  β-phenylethylamine regulation of dopaminergic nigrostriatal cell activity , 1995, Brain Research.

[26]  M. Gassmann,et al.  The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system , 2009, Proceedings of the National Academy of Sciences.

[27]  Marko Hawlina,et al.  Simultaneous in vivo measurement of dopamine, serotonin and ascorbate in the striatum of experimental rats using voltammetric microprobe. , 2006, Frontiers in bioscience : a journal and virtual library.

[28]  A. Boulton.  Identification, distribution, metabolism, and function of meta and para tyramine, phenylethylamine and tryptamine in brain. , 1976, Advances in biochemical psychopharmacology.

[29]  A. Boulton.  Trace Amines and the Neurosciences: An Overview , 1984 .

[30]  V. Chefer,et al.  Endogenous κ-Opioid Receptor Systems Regulate Mesoaccumbal Dopamine Dynamics and Vulnerability to Cocaine , 2005, The Journal of Neuroscience.

[31]  G. Miller,et al.  β-Phenylethylamine Alters Monoamine Transporter Function via Trace Amine-Associated Receptor 1: Implication for Modulatory Roles of Trace Amines in Brain , 2008, Journal of Pharmacology and Experimental Therapeutics.

[32]  J. Shih,et al.  Increased stress response and beta-phenylethylamine in MAOB-deficient mice. , 1997, Nature genetics.

[33]  A. Vaccari.  High affinity binding of [3H]‐tyramine in the central nervous system , 1986, British journal of pharmacology.

[34]  J. Stevens,et al.  Dopamine D1 receptor distribution in Sf9 cells imaged by confocal microscopy: a quantitative evaluation. , 1995, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[35]  D. Perry.  [3H]tryptamine autoradiography in rat brain and choroid plexus reveals two distinct sites. , 1986, Journal of Pharmacology and Experimental Therapeutics.

[36]  G. Bernardi,et al.  Trace amines depress D2‐autoreceptor‐mediated responses on midbrain dopaminergic cells , 2010, British journal of pharmacology.

[37]  H. Bönisch,et al.  Dissociation constants and lipophilicity of catecholamines and related compounds , 1979, Naunyn-Schmiedeberg's Archives of Pharmacology.

[38]  A. Boulton,et al.  Metabolism distribution, and disappearance of injected beta-phenylethylamine in the rat. , 1975, Canadian journal of biochemistry.

[39]  M. Risner,et al.  Characteristics of β-phenethylamine self-administration by dog , 1977, Pharmacology Biochemistry and Behavior.

[40]  S. Westmoreland,et al.  Modulation of Monoamine Transporters by Common Biogenic Amines via Trace Amine-Associated Receptor 1 and Monoamine Autoreceptors in Human Embryonic Kidney 293 Cells and Brain Synaptosomes , 2008, Journal of Pharmacology and Experimental Therapeutics.

[41]  L. Cubeddu,et al.  Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding. , 1988, The Journal of pharmacology and experimental therapeutics.

[42]  S. Haber,et al.  Immunocytochemical localization of the dopamine transporter in human brain , 1999, The Journal of comparative neurology.

[43]  L. Stein.  SELF-STIMULATION OF THE BRAIN AND THE CENTRAL STIMULANT ACTION OF AMPHETAMINE. , 1964, Federation proceedings.

[44]  D. Henry,et al.  Phenylethlamine and P-Tyramine in the Extracellular Space of the Rat Brain: Quantification Using a New Radioenzymatic Assay and in Situ Microdialysis , 1988 .

[45]  A. Juorio.  Presence and metabolism of β-phenylethylamine, p-tyramine, m-tyramine and tryptamine in the brain of the domestic fowl , 1976, Brain Research.

[46]  Sabina Frascarelli,et al.  3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone , 2004, Nature Medicine.

[47]  S. Philips,et al.  THE EFFECTS OF RESERPINE AND 6‐HYDROXYDOPAMINE ON THE CONCENTRATIONS OF SOME ARYLALKYLAMINES IN RAT BRAIN , 1977, British journal of pharmacology.

[48]  G. Miller,et al.  Trace amine-associated receptor 1 as a monoaminergic modulator in brain. , 2009, Biochemical pharmacology.

[49]  A. Boulton,et al.  Metabolism, Distribution, and Disappearance of Infected β-Phenylethylamine in the Rat , 1975 .

[50]  T. Sotnikova,et al.  Pharmacological Characterization of Membrane-Expressed Human Trace Amine-Associated Receptor 1 (TAAR1) by a Bioluminescence Resonance Energy Transfer cAMP Biosensor , 2008, Molecular Pharmacology.

[51]  L. Thorpe,et al.  Plasma phenylethylamine in schizophrenic patients , 1991, Biological Psychiatry.

[52]  N. Zahniser,et al.  Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands. , 2003, European journal of pharmacology.

[53]  Hong Yang,et al.  Primate Trace Amine Receptor 1 Modulation by the Dopamine Transporter , 2005, Journal of Pharmacology and Experimental Therapeutics.

[54]  Y. Tu,et al.  Pharmacologic Characterization of the Cloned Human Trace Amine-Associated Receptor1 (TAAR1) and Evidence for Species Differences with the Rat TAAR1 , 2007, Journal of Pharmacology and Experimental Therapeutics.

[55]  A. Mosnaim,et al.  Tyramine-binding by synaptosomes from rat brain: effect of centrally active drugs. , 1977, Biological Psychiatry.

[56]  M. Risner,et al.  Characteristics of beta-phenethylamine self-administration by dog. , 1977, Pharmacology, biochemistry, and behavior.

[57]  A. A. B. H. A. G. Wijshoff.  Trace Amines: Comparative and Clinical Neurobiology , 2011 .

[58]  S. Westmoreland,et al.  Cloning, expression, and functional analysis of rhesus monkey trace amine‐associated receptor 6: Evidence for lack of monoaminergic association , 2008, Journal of neuroscience research.

[59]  J. Javitch,et al.  Regulation of Dopamine Transporter Function and Cell Surface Expression by D3 Dopamine Receptors* , 2007, Journal of Biological Chemistry.

[60]  L. Dyck.  Release of some endogenous trace amines from rat striatal slices in the presence and absence of a monoamine oxidase inhibitor. , 1989, Life sciences.

[61]  T. Wichmann,et al.  Ultrastructural localization and function of dopamine D1‐like receptors in the substantia nigra pars reticulata and the internal segment of the globus pallidus of parkinsonian monkeys , 2010, The European journal of neuroscience.

[62]  Takeshi Kumazawa,et al.  Increased stress response and β–phenylethylamine in MAOB–deficient mice , 1997, Nature Genetics.

[63]  W. Thompson,et al.  Behavior maintained under fixed-interval and second-order schedules by intravenous injections of endogenous noncatecholic phenylethylamines in dogs. , 1984, The Journal of pharmacology and experimental therapeutics.

[64]  J. Bunzow,et al.  Trace Amine-Associated Receptor 1 Displays Species-Dependent Stereoselectivity for Isomers of Methamphetamine, Amphetamine, and Para-Hydroxyamphetamine , 2007, Journal of Pharmacology and Experimental Therapeutics.

[65]  G. Miller,et al.  A Receptor Mechanism for Methamphetamine Action in Dopamine Transporter Regulation in Brain , 2009, Journal of Pharmacology and Experimental Therapeutics.

[66]  L. Dwoskin,et al.  Nicotinic Receptor Modulation of Dopamine Transporter Function in Rat Striatum and Medial Prefrontal Cortex , 2004, Journal of Pharmacology and Experimental Therapeutics.

[67]  K. Kellar,et al.  [3H]Tryptamine: high affinity binding sites in rat brain. , 1982, European journal of pharmacology.

[68]  T. Spencer,et al.  Modafinil Occupies Dopamine and Norepinephrine Transporters in Vivo and Modulates the Transporters and Trace Amine Activity in Vitro , 2006, Journal of Pharmacology and Experimental Therapeutics.

[69]  M. Reith,et al.  Is Na+ required for the binding of dopamine, amphetamine, tyramine, and octopamine to the human dopamine transporter? , 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

[70]  S. Andreescu,et al.  Amperometric detection of dopamine in vivo with an enzyme based carbon fiber microbiosensor. , 2010, Analytical chemistry.

[71]  A. Marty,et al.  Extrasynaptic Vesicular Transmitter Release from the Somata of Substantia Nigra Neurons in Rat Midbrain Slices , 1998, The Journal of Neuroscience.

[72]  S. Cooper,et al.  beta-Phenylethylamine-, d-amphetamine-and l-amphetamine-induced place preference conditioning in rats. , 1983, European journal of pharmacology.

[73]  J. Mesonero,et al.  Expression of 5-HT1A and 5-HT7 receptors in Caco-2 cells and their role in the regulation of serotonin transporter activity. , 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[74]  J. Phillis,et al.  Iontophoretic studies of some trace amines in the mammalian CNS , 1979, Brain Research.

[75]  A. Greenshaw,et al.  Reciprocal changes in striatal dopamine and β-phenylethylamine induced by reserpine in the presence of monoamine oxidase inhibitors , 1988, Naunyn-Schmiedeberg's Archives of Pharmacology.

[76]  R. De La Garza,et al.  Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity. , 2001, Brain research. Molecular brain research.

[77]  J. O. Schenk,et al.  Striatal Transporter for Dopamine: Catechol Structure‐Activity Studies and Susceptibility to Chemical Modification , 1994, Journal of neurochemistry.

[78]  C. Altar,et al.  Autoradiographic localization and pharmacology of unique [3H]tryptamine binding sites in rat brain , 1986, Neuroscience.

[79]  R. Schmitt,et al.  Beitrag zur Kenntniss des Tyrosins , 1865 .

[80]  G. Bernardi,et al.  Inhibitory effects of trace amines on rat midbrain dopaminergic neurons , 2004, Neuropharmacology.

[81]  E. V. Van Bockstaele,et al.  Cannabinoid modulation of cortical adrenergic receptors and transporters , 2009, Journal of neuroscience research.

[82]  A. Boulton,et al.  Distribution, metabolism, and disappearance of intraventricularly injected p-tyramine in the rat. , 1974, Canadian journal of biochemistry.

[83]  A. Janowsky,et al.  Effects of Methamphetamine and Lobeline on Vesicular Monoamine and Dopamine Transporter-Mediated Dopamine Release in a Cotransfected Model System , 2004, Journal of Pharmacology and Experimental Therapeutics.

[84]  Martin Ebeling,et al.  Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors. , 2005, Genomics.

[85]  T. Sotnikova,et al.  The Dopamine Metabolite 3-Methoxytyramine Is a Neuromodulator , 2010, PloS one.

[86]  C. Swanson,et al.  The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia , 2007, Genes, brain, and behavior.

[87]  A. Boulton,et al.  Absence of 2-phenylethylamine binding after monoamine oxidase inhibition in rat brain. , 1992, European journal of pharmacology.

[88]  Beth Borowsky,et al.  Trace amines: Identification of a family of mammalian G protein-coupled receptors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[89]  R. Wyatt,et al.  Regional differences in catecholamine formation and metabolism in the rat spinal cord , 1981, Brain Research.

[90]  G. Miller,et al.  Trace Amine-Associated Receptor 1 Is a Modulator of the Dopamine Transporter , 2007, Journal of Pharmacology and Experimental Therapeutics.

[91]  S. Zail,et al.  Effect of ethanol on liver 8-aminolaevulinate synthetase in rats. , 1968 .

[92]  G. Reynolds,et al.  Deficient production of tyramine and octopamine in cases of depression , 1979, Nature.

[93]  R. Neubig,et al.  International Union of Pharmacology. LXXII. Recommendations for Trace Amine Receptor Nomenclature , 2009, Pharmacological Reviews.

[94]  Mark D. Berry,et al.  Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators , 2004, Journal of neurochemistry.